We are live on
!
Find out more
Xponance Portfolio holdings
AUM
$16.3B
Turnover
12.69%
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
-2.91%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$14.1B
AUM Growth
+$741M
(+5.6%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Avg Time Held
3.5
years
Top 10 Avg Time Held
4.8
years
Top 20 Avg Time Held
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$110M |
| 2 |
Apple
AAPL
|
+$89M |
| 3 |
Microsoft
MSFT
|
+$81.1M |
| 4 |
Amazon
AMZN
|
+$54.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$45.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$4.8M |
| 2 |
KeyCorp
KEY
|
+$4.08M |
| 3 |
Solstice Advanced Materials
SOLS
|
+$3.06M |
| 4 |
Valero Energy
VLO
|
+$2.61M |
| 5 |
Monster Beverage
MNST
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Financials | 11.04% |
| 3 | Consumer Discretionary | 10.62% |
| 4 | Communication Services | 10.59% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1051
Westlake Corp
WLK
$7.95B
| $466K | ﹤0.01% |
3,988
+887
| +29% | +$86K |
2022 Q4
13 quarters
|
|
1052
Lincoln National
LNC
$7.7B
| $465K | ﹤0.01% |
13,092
+3,474
| +36% | +$133K |
2024 Q3
6 quarters
|
|
1053
Exponent
EXPO
$3.38B
| $463K | ﹤0.01% |
7,100
+989
| +16% | +$70.3K |
2021 Q2
19 quarters
|
|
1054
KB Home
KBH
$2.55B
| $462K | ﹤0.01% |
8,933
+1,193
| +15% | +$70.2K |
2020 Q2
23 quarters
|
|
1055
CarMax
KMX
$7.07B
| $461K | ﹤0.01% |
11,085
+3,267
| +42% | +$143K |
2020 Q2
23 quarters
|
|
1056
DELISTED
Terns Pharmaceuticals
TERN
| $459K | ﹤0.01% |
8,709
+2,032
| +30% | +$83.5K |
2025 Q4
1 quarter
|
|
1057
EPR Properties
EPR
$4.18B
| $457K | ﹤0.01% |
9,155
+2,149
| +31% | +$118K |
2020 Q2
23 quarters
|
|
1058
MarketAxess Holdings
MKTX
$5.79B
| $457K | ﹤0.01% |
2,769
+838
| +43% | +$147K |
2020 Q2
23 quarters
|
|
1059
TG Therapeutics
TGTX
$8.32B
| $454K | ﹤0.01% |
13,679
+2,161
| +19% | +$64.4K |
2024 Q3
6 quarters
|
|
1060
SAP
SAP
$254B
| $451K | ﹤0.01% |
2,634
+604
| +30% | +$125K |
2024 Q1
8 quarters
|
|
1061
Joby Aviation
JOBY
$4.59B
| $448K | ﹤0.01% |
54,287
+16,226
| +43% | +$183K |
2022 Q2
15 quarters
|
|
1062
Kymera Therapeutics
KYMR
$8.88B
| $448K | ﹤0.01% |
5,374
+869
| +19% | +$68.8K |
2025 Q3
2 quarters
|
|
1063
Phillips Edison & Co
PECO
$4.84B
| $447K | ﹤0.01% |
11,935
+1,935
| +19% | +$71.9K |
2022 Q4
13 quarters
|
|
1064
Patterson-UTI
PTEN
$4.4B
| $445K | ﹤0.01% |
41,101
+14,104
| +52% | +$121K |
2022 Q2
15 quarters
|
|
1065
Gates Industrial Corp
GTES
$6.54B
| $445K | ﹤0.01% |
19,672
+5,880
| +43% | +$143K |
2024 Q4
5 quarters
|
|
1066
Kilroy Realty
KRC
$3.87B
| $445K | ﹤0.01% |
15,760
+3,259
| +26% | +$107K |
2020 Q2
23 quarters
|
|
1067
Rhythm Pharmaceuticals
RYTM
$5.97B
| $434K | ﹤0.01% |
4,990
+721
| +17% | +$70.1K |
2024 Q4
5 quarters
|
|
1068
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.66B
| $432K | ﹤0.01% |
11,757
+2,064
| +21% | +$73.5K |
2024 Q2
7 quarters
|
|
1069
Boot Barn
BOOT
$3.42B
| $432K | ﹤0.01% |
2,950
+474
| +19% | +$85.9K |
2024 Q2
7 quarters
|
|
1070
Compass
COMP
$6.72B
| $432K | ﹤0.01% |
59,053
+20,518
| +53% | +$216K |
2022 Q2
15 quarters
|
|
1071
United Microelectronic
UMC
$53.7B
| $431K | ﹤0.01% |
47,952
+27,458
| +134% | +$268K |
2025 Q1
4 quarters
|
|
1072
GlobalFoundries
GFS
$27.3B
| $429K | ﹤0.01% |
9,653
+3,725
| +63% | +$164K |
2025 Q3
2 quarters
|
|
1073
Banco Santander
SAN
$194B
| $429K | ﹤0.01% |
38,009
+9,334
| +33% | +$111K |
2023 Q3
10 quarters
|
|
1074
Shinhan Financial Group
SHG
$33.2B
| $428K | ﹤0.01% |
6,984
+3,142
| +82% | +$193K |
2025 Q4
1 quarter
|
|
1075
Liberty Energy
LBRT
$2.94B
| $425K | ﹤0.01% |
14,772
+2,342
| +19% | +$59.7K |
2023 Q4
9 quarters
|
|
Similar funds
NMO
Xponance's Q1 2026 Portfolio in Review
As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.
- Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
- Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
- Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
- Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
- Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
- Xponance opened 165 new positions and closed 49 in Q1 2026.
- Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.